RVPHW
Reviva Pharmaceuticals Holdings, Inc.
Set alert
0.00 USD 0.00 -16.67%
0.003 Day range 0.0046
0.003 52-week range 0.0046
- YTD
- 0.00%
- 1 year
- 0.00%
- Open
- 0.041
- Prev close
- 0.0036
- Mkt cap
- 343.91K
- Vol
- 303.38K
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.003
- High
- 0.0046
- Forward P/E
- 0.00
- Beta
- -0.06
- Short ratio
- 0.00
- Inst. own
- 0.00%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 0.00
- 200-d avg
- 0.00
- 1y target
- 0.00
Financial health
Altman Z-Score
-15.27 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
3 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
Valuation
P/E -1.0×
FY 2018 5y median -2.9× FY 2025
P/S 0.0×
FY 2018 5y median 0.0× FY 2025
P/B 2.3×
FY 2018 5y median 9.9× FY 2025
P/FCF -0.8×
FY 2018 5y median -4.0× FY 2025
EV/EBITDA -0.3×
FY 2018 5y median 16.4× FY 2025
EV/Sales 0.0×
FY 2018 5y median 0.0× FY 2025
FCF Yield -121.5%
FY 2018 5y median -25.0% FY 2025
Profitability
Gross Margin 0.0%
FY 2018 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2018 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2018 5y median 0.0% FY 2025
ROE -229.7%
FY 2018 5y median -290.0% FY 2025
ROIC -223.1%
FY 2018 5y median -223.1% FY 2025
ROA -124.8%
FY 2018 5y median -128.6% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2018 FY 2025
Operating Income 34.4%
FY 2018 FY 2025
EPS (diluted) 69.6%
FY 2018 FY 2025
Free Cash Flow 26.7%
FY 2018 FY 2025
Financial Health
Current Ratio 2.1×
FY 2018 5y median 1.9× FY 2025
Quick Ratio 2.1×
FY 2018 5y median 1.9× FY 2025
Debt / Equity 0.0×
FY 2018 5y median 0.0× FY 2025
Net Debt / EBITDA 0.7×
FY 2018 5y median -4.7× FY 2025
Interest Coverage -1507×
FY 2018 5y median -1507× FY 2025
Dividends
Dividend Yield 0.0%
FY 2018 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2018 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31